Browse Category

Company Analysis News 17 December 2025

Coherent Corp. Stock (COHR) Jumps on Morgan Stanley Price-Target Hike as New SEC Filings Spotlight Bain Share Overhang (Dec. 17, 2025)

Coherent Corp. Stock (COHR) Jumps on Morgan Stanley Price-Target Hike as New SEC Filings Spotlight Bain Share Overhang (Dec. 17, 2025)

Coherent Corp. (NYSE: COHR) is back in the spotlight on December 17, 2025, as the stock outperformed in early trading following a fresh Wall Street price-target increase—while a pair of recent SEC filings adds new context for investors watching share supply, sponsor selling, and how the company is now reporting its fastest-growing business lines. SEC+3Nasdaq+3GuruFocus+3 In today’s market chatter, two narratives are colliding: Below is what matters in the latest Coherent stock news, forecasts, and analysis—grounded in what’s been filed and published as of 17.12.2025. What’s happening with COHR stock today Coherent shares were among notable gainers in early Wednesday
TeraWulf (WULF) Stock News Today (Dec. 17, 2025): AI Data Center Pivot, Bitcoin Volatility, Dilution Fears, and a High-Stakes Zoning Fight

TeraWulf (WULF) Stock News Today (Dec. 17, 2025): AI Data Center Pivot, Bitcoin Volatility, Dilution Fears, and a High-Stakes Zoning Fight

TeraWulf Inc. (NASDAQ: WULF) is back in the spotlight on Wednesday, December 17, 2025—but not for the reasons bulls may prefer. After one of the most explosive rallies in the Bitcoin-miner-turned-AI-infrastructure theme this year, WULF stock is sliding again, caught between near-term crypto sensitivity and a longer-term narrative built around high-performance computing (HPC) and AI data center leasing. As of late trading (18:28 UTC), WULF was at about $11.81, down roughly 9% on the day, with heavy volume and a wide intraday range that underscores how quickly sentiment can swing in this name. At the same time, Bitcoin itself is
Johnson & Johnson Stock (JNJ) News Today: RBC Raises Target to $240 as FDA Actions and Talc Verdict Shape the 2026 Outlook

Johnson & Johnson Stock (JNJ) News Today: RBC Raises Target to $240 as FDA Actions and Talc Verdict Shape the 2026 Outlook

CAs of Wednesday, December 17, 2025, Johnson & Johnson (NYSE: JNJ) is back in focus for investors looking for a “defensive” large-cap healthcare stock—while also weighing two forces that can move JNJ shares quickly: drug pipeline catalysts and talc litigation headlines. JNJ shares are trading around $210 today, after a volatile stretch that included a sharp pullback on Tuesday, December 16, and renewed analyst attention mid-week. StockAnalysis JNJ stock snapshot: where shares stand on December 17, 2025 JNJ is hovering near the low-$210s, a level that puts the stock close to recent highs for 2025—an important context point because it
Warner Bros. Discovery (WBD) Series A Stock Today: Board Rejects Paramount’s $30 Bid, Backs Netflix Deal — News, Forecasts, and What Investors Are Watching (Dec. 17, 2025)

Warner Bros. Discovery (WBD) Series A Stock Today: Board Rejects Paramount’s $30 Bid, Backs Netflix Deal — News, Forecasts, and What Investors Are Watching (Dec. 17, 2025)

Warner Bros. Discovery, Inc. Series A Common Stock (NASDAQ: WBD) is trading in the middle of one of the most dramatic M&A battles the media industry has seen in years, after the company’s board formally urged shareholders not to tender into Paramount Skydance’s hostile offer and to instead support Warner Bros. Discovery’s already-signed combination with Netflix. Nasdaq+1 WBD stock price on Dec. 17, 2025: the market is pricing a “deal probability” spread As of the latest reported trade on December 17, 2025, WBD stock was $28.455, down $0.445 from the prior close (about -1.54%), with heavy trading volume. That price
StubHub (STUB) Stock News Today (17.12.2025): Partnerships Lift Shares as 13F Buying and Lawsuit Headlines Shape the Outlook

StubHub (STUB) Stock News Today (17.12.2025): Partnerships Lift Shares as 13F Buying and Lawsuit Headlines Shape the Outlook

NEW YORK — December 17, 2025 — StubHub Holdings, Inc. (NYSE: STUB) is back in the spotlight on Wednesday as investors weigh a busy mix of catalysts: an expansion of “Direct Issuance” partnerships that adds more primary-ticket inventory to StubHub’s ecosystem, a newly surfaced institutional position disclosed in a recent 13F filing, and a fresh wave of shareholder-law-firm announcements tied to ongoing securities litigation around the company’s post-IPO disclosures. At the center of today’s conversation is a simple question for markets: Is StubHub’s post-IPO dip a bargain entry into a scaled global ticket marketplace — or a value trap facing
SQM Stock Surges on Lithium Price Spike and JPMorgan Upgrade: News, Forecasts and What to Watch (Dec. 17, 2025)

SQM Stock Surges on Lithium Price Spike and JPMorgan Upgrade: News, Forecasts and What to Watch (Dec. 17, 2025)

Sociedad Química y Minera de Chile S.A. (NYSE: SQM) — one of the world’s best-known lithium producers — is in focus on Wednesday, December 17, 2025, as a sharp move in China’s lithium market and a high-profile Wall Street upgrade combine to lift sentiment across the sector. SQM shares were up sharply in early U.S. trading, changing hands around $69.10 (up about 7.7%) as of 10:12 a.m. ET. Below is a detailed rundown of today’s key news, the latest forecasts and analyst calls, and the catalysts (and risks) investors are watching next. Why SQM stock is rallying today Two storylines
Eli Lilly Stock News Today (Dec. 17, 2025): LLY Holds Near Record Highs as Analysts Lift Targets and Obesity Pipeline Momentum Builds

Eli Lilly Stock News Today (Dec. 17, 2025): LLY Holds Near Record Highs as Analysts Lift Targets and Obesity Pipeline Momentum Builds

Eli Lilly and Company (NYSE: LLY) stock traded in the mid-$1,050s in U.S. session Wednesday, December 17, 2025, hovering near recent highs as investors weighed fresh analyst commentary and new partnership headlines against an already-strong run for the pharma giant. In early trading, LLY was modestly higher, with the session range spanning roughly $1,051 to $1,064. The near-term story for Eli Lilly stock remains dominated by one theme: sustained demand for its GLP-1/“incretin” portfolio (Mounjaro and Zepbound today, and a growing next-generation pipeline for tomorrow). But the market is also increasingly focused on what comes next—especially the oral obesity candidate
Agape ATP Corporation (ATPC) Stock News Today: After-Hours Spike on Dec. 17, 2025 as Investors Weigh Volatility Statement, Proxy Proposals, and Forecast Signals

Agape ATP Corporation (ATPC) Stock News Today: After-Hours Spike on Dec. 17, 2025 as Investors Weigh Volatility Statement, Proxy Proposals, and Forecast Signals

Agape ATP Corporation (NASDAQ: ATPC) is back on traders’ radars on December 17, 2025, after a sharp after-hours move to around $0.13 following a regular-session close near $0.09. Benzinga+2Public+2 That bounce is the latest twist in what can only be described as a violent December tape for ATPC: the stock suffered a single-day plunge of roughly 95% on Dec. 10, then staged a dramatic rebound the next session with extraordinary volume, before sliding again into mid-December. StockAnalysis So what’s behind today’s headline move—and what are investors focusing on next? The short answer: (1) the company’s recent statement addressing the volatility,
Vision Marine Technologies Stock (NASDAQ: VMAR) Surges on Massive Volume as SEC Filing Details a Potential $8M Share Offering (Dec. 17, 2025)

Vision Marine Technologies Stock (NASDAQ: VMAR) Surges on Massive Volume as SEC Filing Details a Potential $8M Share Offering (Dec. 17, 2025)

Dec. 17, 2025 — Vision Marine Technologies Inc. (NASDAQ: VMAR) is back on traders’ radar after a dramatic spike in price and volume, followed by renewed debate over dilution risk tied to a freshly amended securities filing. The move has been eye-catching even by micro-cap standards: intraday swings, unusually heavy participation, and the kind of “what just happened?” tape action that often appears when momentum collides with financing mechanics. Below is what’s driving Vision Marine Technologies stock today, what the company’s filing actually says, and what investors are watching next. VMAR stock today: explosive volume, sharp swings, and volatility signals
Anglo American (AAL) Jumps as Canada Approves Anglo‑Teck Merger: Key Commitments, Timeline, and What Comes Next (Dec. 17, 2025)

Anglo American (AAL) Jumps as Canada Approves Anglo‑Teck Merger: Key Commitments, Timeline, and What Comes Next (Dec. 17, 2025)

Anglo American (LSE: AAL) rises after Canada clears the Anglo‑Teck merger under the Investment Canada Act. Here’s what investors should watch next. Anglo American plc (LSE: AAL) is back in the spotlight today after the company confirmed a major regulatory breakthrough for its proposed “merger of equals” with Canada’s Teck Resources—one of the defining mining deals of 2025 and a bellwether for how governments are approaching critical minerals in an era of electrification and supply-chain security. In a regulatory news release dated 17 December 2025, Anglo American said it and Teck have received Government of Canada approval under the Investment
British American Tobacco (BATS.L / BTI) Stock: Today’s Buyback Update, Dividend Dates, and 2026 Outlook (Dec. 17, 2025)

British American Tobacco (BATS.L / BTI) Stock: Today’s Buyback Update, Dividend Dates, and 2026 Outlook (Dec. 17, 2025)

British American Tobacco p.l.c. (BAT) entered mid-December with its share price near multi-year highs, and the news flow on Wednesday, December 17, 2025 is very “capital allocation meets governance”: the company disclosed another daily share repurchase under its ongoing buyback programme and filed a director declaration under UK listing rules. Meanwhile, investors are still digesting BAT’s early-December FY2025 pre-close trading update, where management reaffirmed its medium-term growth algorithm but signaled that 2026 performance is likely to land at the lower end of its target range—largely because the U.S. vaping market remains distorted by illicit competition and uneven enforcement. Reuters+4Investing.com+4Moneyweb+4 Below
Epack Durable Limited Stock Surges on Heavy Volumes: What’s Driving EPACK Share Price, Analyst Targets, and the Hisense JV Timeline (Dec 17, 2025)

Epack Durable Limited Stock Surges on Heavy Volumes: What’s Driving EPACK Share Price, Analyst Targets, and the Hisense JV Timeline (Dec 17, 2025)

Epack Durable Limited (NSE: EPACK, BSE: 544095) is back in the spotlight on Wednesday, December 17, 2025—and not quietly. The stock extended a sharp two-day rebound, with multiple market trackers flagging unusually high volumes and a fast move off recent lows, after a bruising stretch that followed a weak September-quarter print. Business Standard+2The Economic Times+2 So what’s actually happening here: a fundamentals-driven rerating… a technical snapback… or a bit of both? Below is a clean, publication-ready breakdown of (1) today’s action, (2) the underlying business and earnings context, (3) the freshest broker forecasts and price targets circulating in late 2025,
1 42 43 44 45 46 78

Stock Market Today

South32 share price drops 4% in ASX rout — what investors watch before results

South32 share price drops 4% in ASX rout — what investors watch before results

7 February 2026
South32 shares fell 4.1% to A$4.41 Friday as Australian miners dropped in the worst ASX session since April 2025. The S&P/ASX 200 lost 2%, erasing almost A$70 billion in value. South32’s half-year results and interim dividend decision are set for Feb. 12. Markets reopen Monday with investors watching for further volatility.
Wesfarmers share price: what to watch on ASX next week as results loom

Wesfarmers share price: what to watch on ASX next week as results loom

7 February 2026
Wesfarmers shares closed down 1.33% at A$85.04 on Friday, following a sharp drop in the S&P/ASX 200, which fell 2% for its steepest one-day loss in 10 months. Investors are watching for Australia’s household spending data next week and Wesfarmers’ half-year results due Feb. 19.
Go toTop